Merz Therapeutics
June 23, 2026
Theater 4
Type: Company Presentation
Focus Area:
Other
Merz Therapeutics is a specialty neurology biopharma focused on movement disorders, rare and orphan neurological diseases and chronic pain.
Areas of highest interest include, Multiple Sclerosis, Parkinson’s Disease and other diseases characterized by motor dysfunction such as dystonia, spasticity, blepharospasm, Ataxia, Rare and orphan neurological disorders, ideally with movement disorder aspects, Migraine and chronic pain, e.g. neuropathic pain.
Company HQ City:
Raleigh
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
1908
Lead Product in Development:
Xeomin
CEO
Stefan König
Development Phase of Lead Product
Multiple Products in Market
Number of Unlicensed Products Looking for Licensing
0
When you expect your next catalyst update?
N/A
What is your next catalyst (value inflection) update?
N/A
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}